Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Mukil Natarajan, MD

US FDA

Disclosure(s): No financial relationships to disclose

Poster(s):

2235 - Discordance of Clinical and Microbiological Endpoints in Clinical Trials for Complicated Urinary Tract Infection (cUTI)
Saturday, October 22, 2022
12:15 PM – 1:30 PM US ET